DIN 02317192 — APRI 21 0.15 MG; 0.03 MG
APRI 21 is a tablet of Desogestrel / Ethinyl Estradiol marketed by TEVA CANADA LIMITED. The full Desogestrel / Ethinyl Estradiol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02317192
- Brand name
- APRI 21
- Active ingredient
- Desogestrel / Ethinyl Estradiol
- Strength
- 0.15 MG; 0.03 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Combined oral contraceptive (estrogen-progestin)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Desogestrel / Ethinyl Estradiol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02317206 | APRI 28 | 0.03 MG; 0.15 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02396491 | FREYA 21 | 0.03 MG; 0.15 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02396610 | FREYA 28 | 0.03 MG; 0.15 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02272903 | LINESSA 21 | 0.1 MG; 0.025 MG; 0.025 MG; 0.15 MG; 0.025 MG; 0.125 MG | TABLET | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 02257238 | LINESSA 28 | 0.1 MG; 0.025 MG; 0.025 MG; 0.025 MG; 0.125 MG; 0.15 MG | TABLET | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 02042487 | MARVELON 21 | 0.03 MG; 0.15 MG | TABLET | ORGANON CANADA INC. | MARKETED |
| 02042479 | MARVELON 28 | 0.15 MG; 0.03 MG | TABLET | ORGANON CANADA INC. | MARKETED |
| 02556553 | MILEY 21 | 0.03 MG; 0.15 MG | TABLET | AMBICARE PHARMACEUTICALS INC. | MARKETED |
| 02556561 | MILEY 28 | 0.03 MG; 0.15 MG | TABLET | AMBICARE PHARMACEUTICALS INC. | MARKETED |
| 02410249 | MIRVALA 21 | 0.1500 MG; 0.0300 MG | TABLET | APOTEX INC | MARKETED |
| 02410257 | MIRVALA 28 | 0.0300 MG; 0.1500 MG | TABLET | APOTEX INC | MARKETED |